Ion Beam Applications SA (EBR:IBAB)
Belgium · Delayed Price · Currency is EUR 16.00
-0.46 (-2.79%)
Oct 30, 2026, 5:35 PM CET
Ion Beam Applications Revenue
Ion Beam Applications had revenue of 323.75M EUR in the half year ending June 30, 2026, with 49.01% growth. This brings the company's total for the last twelve months to 639.00M, up 9.08% year-over-year. In the year 2025, Ion Beam Applications had annual revenue of 620.18M with 24.49% growth. That makes Ion Beam Applications the 9,279th largest company in the world by revenue and 39th in Belgium.
Revenue (ttm)
639.00M
Revenue Growth
+9.08%
P/S Ratio
0.73
Revenue / Employee
282.24K
Employees
2,264
Market Cap
465.41M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Ion Beam Applications breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 620.18M | 122.02M | 24.49% |
| Dec 31, 2024 | 498.16M | 31.49M | 6.75% |
| Dec 31, 2023 | 466.67M | 105.40M | 29.17% |
| Dec 31, 2022 | 361.27M | 48.31M | 15.44% |
| Dec 31, 2021 | 312.96M | 1.01M | 0.32% |
| Dec 31, 2020 | 311.96M | 29.40M | 10.41% |
| Dec 31, 2019 | 282.55M | 25.15M | 9.77% |
| Dec 31, 2018 | 257.41M | 20.92M | 8.85% |
| Dec 31, 2017 | 236.49M | -92.29M | -28.07% |
| Dec 31, 2016 | 328.77M | 58.42M | 21.61% |
| Dec 31, 2015 | 270.36M | 49.78M | 22.57% |
| Dec 31, 2014 | 220.58M | 8.07M | 3.80% |
| Dec 31, 2013 | 212.51M | -8.59M | -3.89% |
| Dec 31, 2012 | 221.11M | 17.94M | 8.83% |
| Dec 31, 2011 | 203.17M | -5.87M | -2.81% |
| Dec 31, 2010 | 209.04M | -150.12M | -41.80% |
| Dec 31, 2009 | 359.16M | 26.55M | 7.98% |
| Dec 31, 2008 | 332.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 8.52B |
| argenx SE | 5.21B |
| Fagron NV | 1.03B |
| European Medical Solutions | 51.36M |
| Nyxoah | 21.66M |
| Hyloris Pharmaceuticals | 9.83M |
| Onward Medical | 8.42M |
| Sequana Medical NV | 105.50K |
Ion Beam Applications News
- 9 days ago - IBA Treats First Patient In ConformalFLASH Head And Neck Cancer Trial - Nasdaq
- 4 weeks ago - Ion Beam Enters Distribution Agreement For ARTMS' QIS Technology - Nasdaq
- 2 months ago - Ion Beam Applications Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Ion Beam Applications Earnings release: Q2 2026 - Filings
- 2 months ago - Ion Beam Applications Slides: Q2 2026 - Filings
- 5 months ago - Ion Beam Applications Earnings release: Q1 2026 - Filings
- 7 months ago - Ion Beam Applications Earnings Call Transcript: H2 2025 - Transcripts
- 7 months ago - Ion Beam Applications Earnings release: H2 2025 - Filings